News >

OCM Participants Consider Costs of 2-Sided Risk

Rachel Narozniak, MA
Published: Monday, Nov 25, 2019

Barbara McAneny, MD, a managing partner of New Mexico Oncology Hematology Consultants, Ltd

Barbara McAneny, MD

After 3 years of struggling to meet targets for improved care quality and cost efficiency, many of the 175 practices that have remained in the Oncology Care Model (OCM) of the Centers for Medicare & Medicaid Services (CMS) have a decision to make: Assume a share of the downside risk for failure to meet financial targets or exit the OCM by December 3.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication